Abstract
1.Phencyclidine (PCP) is an inhibitor of the nicotinic acetylcholine receptor (AChR) with characteristics of an open-channel blocker. The location of PCP binding site on the AChR molecule is unknown.
2.PCP inhibits the AChR from electric organ with a higher potency than muscle AChR. To find the molecular basis of this difference, we expressed the two native and six hybrid receptors, and two receptors containing mutated mouse γ subunits in Xenopus laevis oocytes. The inhibition of ACh-induced current in these receptors by PCP was studied using whole-cell voltage-clamp. All hybrid receptors generated robust ACh-induced currents, while incomplete receptors (γ-less or δ-less) did not.
3.PCP potency was higher on hybrids containing Torpedo β and γ subunits regardless of the α and δ subunit origin. A mouse γ subunit containing the asparagine 6′ to the serine mutation in the M2 segment conferred a high sensitivity to PCP.
4.These results support the conclusion that the amino acid residues at the position 6′ of the M2 segments contribute to the PCP potency difference between Torpedo and mouse receptors.
5.Another noncompetitive inhibitor of the AChR, the cembranoid eupalmerin acetate (EUAC), also inhibited the electric organ receptor with a somewhat higher potency than muscle AChR. However, the IC50 values for EUAC inhibition of hybrid receptors did not follow the pattern observed for PCP. Therefore, these two inhibitors interact differently with the AChR molecule.
Article PDF
Similar content being viewed by others
REFERENCES
Albuquerque, E. X., Tsai, M.-C., Aronstam, R. S., Witkop, B., Eldefrawi, A. T., and Eldefrawi, M. E. (1980). Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc. Natl. Acad. Sci. USA 77:1224–1228.
Arias, H. R. (1997). Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res. Rev. 25:133–191.
Blanton, M. P., Dangott, L. J., Raja, S. K., Lala, A. K., and Cohen, J. B. (1998). Probing the structure of the nicotinic acetylcholine receptor ion channel with the uncharged photoactivable compound [3H]diazofluorene. J. Biol. Chem. 273:8659–8668.
Changeux, J.-P., Pinset, C., and Ribera, A. B. (1986). Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics. J. Physiol. 378:497–513.
Charnet, P., Labarca, C., Leonard, R. J., Vogelaar, N. J., Czyzyk, L., Gouin, A, Davidson, N., and Lester, H. A. (1990). An open-channel blocker interacts with adjacent turns of α-helices in the nicotinic acetylcholine receptor. Neuron 2:87–95.
DiPaola M., Kao, P. N., and Karlin, A. (1990). Mapping of the α-subunit site photolabeled by the noncompetitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor. J. Biol. Chem. 265:11017–11029.
Donnelly-Roberts, D. L., and Lentz, T. L. (1991). Binding sites of α-bungarotoxin and the noncompetitive inhibitor phencyclidine on a synthetic peptide comprising residues 172–227 of the α-subunit of the nicotinic acetylcholine receptor. Biochemistry 30:7484–7491.
Eaton, M. J., Pagán, O. R., Hann, R. M., and Eterović, V. A. (1997). Differential effects of dimethyl sulfoxide on nicotinic acetylcholine receptor from mouse muscle and Torpedo electrocytes. Neurosci. Lett. 230:163–166.
Eaton, M. J., Labarca C. G., and Eterović, V. A. (1998). Differential effect of mutations in the M2 membrane spanning region of the nicotinic acetylcholine receptor on the action of phencyclidine at its high and low affinity sites. Biophys. J. 74:A91.
Eterović, V. A., and Hann, R. M. (1995). Noncompetitive inhibitors of the acetylcholine receptor help paint a picture of its ion channel. Puerto Rico Health Sci. J. 14:199–209.
Eterović, V. A., Hann, R. M., Ferchmin, P. A., Rodríguez, A. D., Li, L., Lee, Y. H., and McNamee, M. G. (1993a). Diterpenoids from Caribbean Gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor. Cell. Mol. Neurobiol. 13:99–110.
Eterović, V. A., Li, L., Ferchmin, P. A., Lee, Y. H., Hann, R. M., Rodríguez, A. D., and McNamee, M. G. (1993b). The ion channel of mouse and electric organ acetylcholine receptors: Differing affinities for noncompetitive inhibitors. Cell. Mol. Neurobiol. 13:111–121.
Eterović, V. A., Eakin, A. E., Ferchmin, P. A., and Lu, R. (1995a). Phencyclidine binding site on the acetylcholine receptor. Soc. Neurosci. Abstr. 21(1):9.
Eterović, V. A., Hann, R. M., Lu, R., Ferchmin, P. A., Pagan, O. R., Rodríguez, A. D., Vali, S., and McNamee, M. G. (1995b). The nicotinic acetylcholine receptor: Inhibitor tales. Proc. X. Annu. Meet. Argentin. Soc. Neurochem., p. 26.
Fontan, L. A., Yoshida, W. Y., and Rodríguez, A. D. (1990). Application of two-dimensional NMR spectroscopy in the structural determination of marine natural products. Total structural assignment of the cembranoid diterpene eupalmerin acetate through the use of two-dimensional 1H-1H, 1H-13C, and 13C-13C chemical shift correlation spectroscopy. J. Org. Chem. 55:4956–4960.
Francis, M. M., Choi, K., II, Horenstein, B. A., and Papke, R. L. (1998). Sensitivity to voltage-independent inhibition determined by pore-lining region of the acetylcholine receptor. Biophys. J. 74:2306–2317.
Giraudat, J., Dennis, M., Heidmann, T., Chang, J.-Y., and Changeux, J.-P. (1986). Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: Serine-262 of the δ subunit is labeled by [3H]chlorpromazine. Proc. Natl. Acad. Sci. USA 83:2719–2723.
Giraudat, J., Dennis, M., Heidmann, T., Haumont, P.-Y., Lederer, F., and Changeux, J.-P. (1987). Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the β and δ chains. Biochemistry 26:2410–2418.
Giraudat, J., Galzi, J.-L., Revah, F., Changeux, J.-P., Haumont, P.-Y., and Lederer, F. (1989). The noncompetitive blocker [3H]chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor alpha-subunit. FEBS Lett. 253:190–198.
Hann, R. M, Pagán, O. R., Gregory, L., Jácome, T., Rodríguez, A. D., Ferchmin, P. A., Lu, R., and Eterović, V. A. (1998). Characterization of cembranoid interaction with the nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 287:253–260.
Haring, R., Kloog, Y., Kalir, A., and Sokolovsky, M. (1983). Species differences determine azido phencyclidine labeling pattern in desensitized nicotinic acetylcholine receptors. Biochem. Biophys. Res. Commun. 113:723–729.
Haring, R., Kloog, Y., and Sokolovsky, M. (1984). Localization of phencyclidine binding sites on α and β subunits of the nicotinic acetylcholine receptor from Torpedo ocellata electric organ using azido phencyclidine. J. Neurosci. 4:627–637.
Heidmann, T., Oswald, R. E., and Changeux, J.-P. (1983). Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry 22:3112–3127.
Hucho, F., Oberthür, W., and Lottspeich, F. (1986). The ion channel of the nicotinic acetylcholine receptor is formed by the homologous helices MII of the receptor subunits. FEBS Lett. 205:137–142.
Karlin, A. (1991). Explorations of the nicotinic acetylcholine receptor. The Harvey Lectures, Series 85, Wiley-Liss, New York, pp. 71–107.
Karpen, J. W., and Hess, G. P. (1986). Cocaine, phencyclidine, and procaine inhibition of the acetylcholine receptor: characterization of the binding site by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles. Biochemistry 25:1777–1785.
Kotzyba-Hibert, F., Langembuch-Cachat, J., Jaganathen, J., Goeldner, M., and Hirth, C. (1985). Aryldiazonium salts as photoaffinity labels of the nicotinic acetylcholine receptor PCP binding site. FEBS Lett. 182:297–301.
Lurtz, M. M., Hareland, M. L., and Pedersen, S. E. (1997). Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica. Biochemistry 36:2068–2075.
Mosckovitz, R., Haring, R., Gershoni, J. M., Kloog, Y., and Sokolovsky, M. (1987). Localization of azidophencyclidine-binding site on the nicotinic acetylcholine receptor alpha-subunit, Biochem. Biophys. Res. Commun. 145:810–816.
Oberthür, W., Muhn, P., Baumann, H., Lottspeich, F., Wittmann-Liebold, B., and Hucho, F. (1986). The reaction site of a non-competitive antagonist in the δ subunit of the nicotinic acetylcholine receptor. EMBO J. 5:1815–1819.
Oswald, R. E., Heidmann, T., and Changeux, J.-P. (1983). Multiple affinity states for noncompetitive blockers revealed by [3H]phencyclidine binding to acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry 22:3128–3136.
Oswald, R. E., Bamberger, M. J., and McLaughlin, J. T. (1984). Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque. Mol. Pharmacol. 25:360–368.
Papke, R. L., and Oswald, R. E. (1989). Mechanisms of noncompetitive inhibition of acetylcholine-induced single-channel currents. J. Gen. Physiol. 93:785–811.
Pedersen, S. E., Sharp, S. D., Liu, W.-S., and Cohen, J. B. (1992). Structure of the non-competitive antagonist-binding site of the Torpedo nicotinic acetylcholine receptor. [3H]Meproadifen mustard reacts selectively with α-subunit Glu-262. J. Biol. Chem. 267:10489–10499.
Revah, F., Galzi, J. L., Giraudat, J., Haumont P.-Y., Lederer, F., and Changeux J.-P. (1990). The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor γ subunit: implications for the α-helical organization of regions MII and for the structure of the ion channel. Proc. Natl. Acad. Sci. USA 87:4675–4679.
Tamamizu, S., Todd, A. P., and McNamee, M. G. (1995). Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine. Cell. Mol. Neurobiol. 15:427–438.
White, B. H., and Cohen, J. B. (1992). Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist. J. Biol. Chem. 267:15770–15783.
White, B. H., Howard, S., Cohen, S. G., and Cohen, J. B. (1991). The hydrophobic photoreagent 3-(trifluoromethyl)-3-m-([125I]iodophenyl)diazirine is a novel noncompetitive antagonist of the nicotinic acetylcholine receptor. J. Biol. Chem. 266:21595–21607.
Yoshii, K., Yu, L., Mixter Mayne, K., Davidson N., and Lester, H. A. (1987). Equilibrium properties of mouse-Torpedo acetylcholine receptor hybrids expressed in Xenopus oocytes. J. Gen. Physiol. 90:553–573.
Yu, L., Leonard, R. J., Davidson, N., and Lester, H. A. (1991). Single-channel properties of mouse-Torpedo acetylcholine receptor hybrids expressed in Xenopus oocytes. Mol. Brain Res. 10:203–211.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eterović, V.A., Lu, R., Eakin, A.E. et al. Determinants of Phencyclidine Potency on the Nicotinic Acetylcholine Receptors from Muscle and Electric Organ. Cell Mol Neurobiol 19, 745–757 (1999). https://doi.org/10.1023/A:1006905106834
Issue Date:
DOI: https://doi.org/10.1023/A:1006905106834